Brainstorm Cell Therapeutics, Inc. Live Share Price Today, Share Analysis and Chart

Name: Brainstorm Cell Therapeutics, Inc.: Is Infosys Ltd. worth buying?
Item: Brainstorm Cell Therapeutics, Inc.
Rating: 1.08750
Author: Trendlyne DVM scores

about

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progr...

1.20 0.00 (0.00%)

67.65% Fall from 52W High

182.2K

XNAS Volume

XNAS 15 Jul, 2025 3:58 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Neutral

43.5 / 100

No estimates available

Brainstorm Cell Therapeuti... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Brainstorm Cell Therapeutics, Inc. Live Share Price Today, Share Analysis and Chart

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progr...

67.65% Fall from 52W High

SWOT Analysis

Brainstorm Cell Therapeuti... Live Price Chart